BLUE - Biolife Solutions: A Diversified Profitable Play On Gene Therapy And Regenerative Medicine
Diversified Play on Burgeoning Gene/Cell Therapy and Regenerative Medicine Market
When looking to invest in the rapidly expanding gene/cell therapy and regenerative medicine space, there are many individual companies that are filled with the inherent binary risk-reward relationship that defines the biotech sector. As this growing segment continues down the path to a large number of regulatory approvals and broader commercial success, there undoubtedly will be many winners and losers commensurate with this risk/reward.
Biolife Solutions (BLFS) represents a unique, diversified play that removes significant risk from the equation tied to company-specific regulatory